Assessment of F/HN-Pseudotyped Lentivirus as a Clinically Relevant Vector for Lung Gene Therapy-Reference-Cited by-同舟云学术

Assessment of F/HN-Pseudotyped Lentivirus as a Clinically Relevant Vector for Lung Gene Therapy

Published:2012-11 Issue:9 Volume:186 Page:846-856
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Griesenbach Uta,Inoue Makoto,Meng Cuixiang,Farley Raymond,Chan Mario,Newman Nikki K.,Brum Andrea,You Jun,Kerton Angela,Shoemark Amelia,Boyd A. Christopher,Davies Jane C.,Higgins Tracy E.,Gill Deborah R.,Hyde Stephen C.,Innes J. Alastair,Porteous David J.,Hasegawa Mamoru,Alton Eric W. F. W.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference25 articles.

1. Progress in Gene and Cell Therapy for Cystic Fibrosis Lung Disease

2. Efficient gene transfer to airway epithelium using recombinant Sendai virus

3. The Nasal Epithelium as a Factory for Systemic Protein Delivery

4. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus

5. Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Dual-Pseudotyped Lentiviral Vector with VSV-G and Sendai Virus HN Enhances Infection Efficiency through the Synergistic Effect of the Envelope Proteins;Viruses;2024-05-23

2. Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa;Molecular Therapy;2024-05

3. Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity;Progress in Retinal and Eye Research;2024-05

4. Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine;Current Medicinal Chemistry;2024-04

5. Advanced approaches to overcome biological barriers in respiratory and systemic routes of administration for enhanced nucleic acid delivery to the lung;Expert Opinion on Drug Delivery;2023-11-02